RxDoctor Payments Data

Severino Pimentel, MD

Family Medicine · Katy, TXNPI 1003844820

Payments from drug & device makers

$22,517in general payments, 2019–2025

Across 193 payments — averaging $116.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$19K
  • Novo Nordisk$505
  • AbbVie$502
  • Janssen Research & Development, LLC$500
  • Nestle Healthcare Nutrition Inc.$342
  • GSK$310
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$3,258100%
  • Education$140%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$22,517 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$50,794
Medicare patients
131
Services billed
1,531

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide251$314,360
MounjaroTirzepatide103$131,786
Humira PenAdalimumab13$103,009
EliquisApixaban60$49,506
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$34,720
ZenpepLipase/Protease/Amylase17$31,640
ProliaDenosumab12$20,793
VascepaIcosapent Ethyl27$20,421
XareltoRivaroxaban20$19,376
Soliqua 100-33Insulin Glargine/Lixisenatide15$16,386
Icosapent Ethyl32$15,691
FarxigaDapagliflozin Propanediol13$13,171
SymbicortBudesonide/Formoterol Fumarate27$12,757
GemtesaVibegron16$6,499
Rosuvastatin Calcium490$6,168

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$505$314,360251 claims
Lilly USA, LLCMounjaro$273$131,786103 claims
PfizerEliquis$18,769$49,50660 claims
GSKTrelegy Ellipta, Breo Ellipta$310$40,16849 claims
Aimmune Therapeutics, Inc.Zenpep$110$31,64017 claims
AstraZenecaFarxiga, Symbicort$98$25,92840 claims
AmgenProlia$41$20,79312 claims
Johnson & JohnsonXarelto$28$19,37620 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$29$16,38615 claims
AbbVieSynthroid$502$2,60848 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Katy

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →